Background: Whereas the normal cornea is devoid of blood and lymphatic vessels,both can invade the cornea secondary to a variety of corneal diseases and after surgery. This not only reduces visual acuity, but also renders such a cornea high-risk, if subsequent corneal transplantation is performed.
Methods: A PUBMED-based literature search was carried out.
Results: Current knowledge on pathogenesis, clinical implications and treatment modalities for corneal neovascularization is discussed.
Conclusions: Novel anti-angiogenic and antilymphangiogenic therapeutic strategies should reduce blindness associated with corneal neovascularization and subsequent graft rejection.